Advances in Smoking Cessation
In the final episode of Kicking the Nicotine Habit, It's a Brain Thing. The MedEvidence! doctors roll out clinical trials on Cytisinicline, an approved therapy in Central and Eastern West Europe for the past 20 years.
Dr. Michael Koren, MedEvidence! Podcast Host, Lead Investigator on 2,000+ clinical trials, and practicing Cardiovascular physician with co-host Michelle McCormick talks with Dr. Mitchell Rothstein a clinical Pulmonary and Sleep Medicine physician for 30 years in the Jacksonville Florida area. Dr. Rothstein transitioned into Clinical Research as the Medical Director of the Phase 1 unit at Jacksonville Center for Clinical Research six years ago.
Inside this episode:
- Cytisinicline
- Alpha4beta2 Nicotine Receptor
- Clinical Trials to help quit smoking
Links to more information:
- A naturally-derived alternative treatment to quit smoking
- Ongoing Research of Cytisinicline for Addiction
- More about Clinical Trial Participation
- Am I eligible to participate in this study?
- Why Should I participate in this study?
- What happens if I volunteer to participate in this study?
- Participate in Clinical Research
Be a part of advancing science by participating in clinical research
Music: Storyblocks - Corporate Inspired
Recorded Date: April 13, 2022
